ICD-10: A06.82

ICD-10 code A06.82 refers to "Other amebic genitourinary infections," which are infections caused by the protozoan parasite Entamoeba histolytica that specifically affect the genitourinary system. This code is part of the broader category of amebiasis, which encompasses various forms of infections caused by this organism.

Clinical Description

Overview of Amebiasis

Amebiasis is primarily known for causing intestinal infections, but it can also lead to extraintestinal manifestations, including genitourinary infections. The most common form of amebiasis is intestinal amebiasis, which can result in symptoms such as diarrhea, abdominal pain, and dysentery. However, when the infection spreads to the genitourinary tract, it can lead to more specific symptoms and complications.

Symptoms of Genitourinary Infections

Patients with other amebic genitourinary infections may present with a variety of symptoms, including:

• Dysuria: Painful urination.
• Hematuria: Blood in the urine.
• Urinary frequency: Increased urge to urinate.
• Pelvic pain: Discomfort in the lower abdomen or pelvic region.
• Vaginal discharge: In females, there may be abnormal discharge.

In severe cases, the infection can lead to complications such as abscess formation in the urinary tract or reproductive organs, which may require surgical intervention.

Diagnosis

Diagnosis of amebic genitourinary infections typically involves:

• Clinical Evaluation: A thorough history and physical examination to assess symptoms.
• Laboratory Tests: Microscopic examination of stool samples for Entamoeba histolytica cysts or trophozoites, and urine tests to identify the presence of the parasite.
• Imaging Studies: Ultrasound or CT scans may be utilized to identify abscesses or other complications in the urinary tract.

Treatment

Treatment for other amebic genitourinary infections generally includes:

• Antimicrobial Therapy: The primary treatment involves the use of specific antibiotics such as metronidazole or tinidazole, which are effective against Entamoeba histolytica.
• Supportive Care: Management of symptoms and hydration is crucial, especially in cases of severe diarrhea or dehydration.

Conclusion

ICD-10 code A06.82 captures a specific and important aspect of amebiasis, focusing on infections that affect the genitourinary system. Understanding the clinical presentation, diagnostic methods, and treatment options is essential for healthcare providers to effectively manage these infections and prevent complications. Proper coding and documentation are vital for accurate billing and healthcare statistics, ensuring that patients receive appropriate care for their conditions.

ICD-10 code A06.82 refers to "Other amebic genitourinary infections," which are caused by the protozoan parasite Entamoeba histolytica. This condition primarily affects the genitourinary system and can present with a variety of clinical features. Below is a detailed overview of the clinical presentation, signs, symptoms, and patient characteristics associated with this diagnosis.

Clinical Presentation

Overview of Amebic Infections

Amebic infections, particularly those caused by E. histolytica, can lead to a range of clinical manifestations, from asymptomatic cases to severe disease. While E. histolytica is most commonly associated with intestinal infections, it can also cause extraintestinal infections, including those affecting the genitourinary tract.

Signs and Symptoms

The symptoms of other amebic genitourinary infections can vary widely among patients. Common signs and symptoms include:

• Dysuria: Painful urination is a frequent complaint among affected individuals.
• Hematuria: The presence of blood in the urine may occur, indicating inflammation or damage to the urinary tract.
• Urinary Frequency and Urgency: Patients may experience an increased need to urinate, often accompanied by a sense of urgency.
• Pelvic Pain: Discomfort or pain in the pelvic region can be a significant symptom, particularly in women.
• Vaginal Discharge: In females, there may be abnormal vaginal discharge, which can be associated with inflammation.
• Fever and Malaise: Systemic symptoms such as fever, chills, and general malaise may also be present, especially in more severe cases.

Complications

In severe cases, complications may arise, including:

• Abscess Formation: The development of abscesses in the genitourinary tract can occur, leading to more severe symptoms and requiring surgical intervention.
• Perforation: Rarely, severe infections can lead to perforation of the bladder or other structures, which is a medical emergency.

Patient Characteristics

Demographics

• Age: While amebic infections can affect individuals of any age, they are more commonly seen in adults.
• Gender: Both males and females can be affected, but certain symptoms may present differently based on gender, particularly in relation to reproductive health.

Risk Factors

Several factors may increase the risk of developing amebic genitourinary infections:

• Geographic Location: Individuals living in or traveling to areas with poor sanitation and hygiene practices are at higher risk.
• Immunocompromised Status: Patients with weakened immune systems, such as those with HIV/AIDS or undergoing immunosuppressive therapy, are more susceptible to severe infections.
• Previous Intestinal Amebiasis: A history of intestinal amebiasis may predispose individuals to extraintestinal infections, including those affecting the genitourinary system.

Behavioral Factors

• Sexual Practices: Certain sexual practices may increase the risk of transmission and infection, particularly in individuals with multiple sexual partners or those engaging in unprotected intercourse.

Conclusion

Amebic genitourinary infections, classified under ICD-10 code A06.82, present with a range of symptoms primarily affecting the urinary tract. Early recognition and treatment are crucial to prevent complications. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with this condition can aid healthcare providers in diagnosing and managing affected individuals effectively. If you suspect an amebic infection, it is essential to seek medical evaluation for appropriate testing and treatment.

The ICD-10 code A06.82 refers to "Other amebic genitourinary infections," which are caused by the protozoan parasite Entamoeba histolytica. Diagnosing this condition involves several criteria and considerations, which can be categorized into clinical presentation, laboratory findings, and epidemiological factors.

Clinical Presentation

Patients with amebic genitourinary infections may present with a variety of symptoms, including:

• Dysuria: Painful urination, which may be accompanied by urgency and frequency.
• Hematuria: Blood in the urine, which can indicate inflammation or infection.
• Pelvic Pain: Discomfort or pain in the pelvic region, which may be associated with other symptoms.
• Fever: A systemic response to infection may present as fever, although it is not always present.

These symptoms can overlap with other genitourinary infections, making clinical evaluation critical.

Laboratory Findings

To confirm a diagnosis of amebic genitourinary infection, healthcare providers typically rely on several laboratory tests:

• Stool Examination: Microscopic examination of stool samples can reveal the presence of Entamoeba histolytica cysts or trophozoites. This is a primary method for diagnosing amebiasis, although it may not directly indicate genitourinary involvement.
• Urine Analysis: A urinalysis may show signs of infection, such as white blood cells, red blood cells, and bacteria, but specific tests for Entamoeba histolytica are less common.
• Serological Tests: Blood tests can detect antibodies against Entamoeba histolytica, which may support the diagnosis, especially in cases where stool examination is inconclusive.
• Imaging Studies: Ultrasound or CT scans may be used to assess for complications or to visualize abscesses in the genitourinary tract.

Epidemiological Factors

Understanding the patient's history and potential exposure to Entamoeba histolytica is crucial:

• Travel History: Recent travel to endemic areas where amebiasis is common can increase the likelihood of infection.
• Exposure to Contaminated Water or Food: Consumption of contaminated food or water is a significant risk factor for acquiring the infection.
• Immunocompromised Status: Individuals with weakened immune systems may be more susceptible to severe infections.

Conclusion

The diagnosis of amebic genitourinary infections classified under ICD-10 code A06.82 requires a comprehensive approach that includes evaluating clinical symptoms, conducting laboratory tests, and considering epidemiological factors. Accurate diagnosis is essential for effective treatment and management of the infection, which may involve antiparasitic medications and supportive care. If you suspect an amebic infection, it is important to consult a healthcare professional for appropriate testing and diagnosis.

A06.82 refers to "Other amebic genitourinary infections," which are caused by the protozoan parasite Entamoeba histolytica. This condition can lead to various complications, including dysuria, hematuria, and pelvic pain. The treatment for amebic infections, particularly those affecting the genitourinary system, typically involves the use of specific medications and supportive care. Below is a detailed overview of standard treatment approaches for this condition.

Pharmacological Treatment

1. Antimicrobial Therapy

The primary treatment for amebic infections is the use of antimicrobial agents. The following medications are commonly prescribed:

• Metronidazole: This is the first-line treatment for Entamoeba histolytica infections. It is effective in treating both intestinal and extraintestinal forms of amebiasis. The typical dosage for adults is 750 mg three times a day for 5 to 10 days, depending on the severity of the infection[1].

• Tinidazole: An alternative to metronidazole, tinidazole is also effective against amebic infections. It is usually administered as a single dose of 2 grams or in a shorter course of 1 gram daily for 3 days[1].

• Iodoquinol: This medication may be used in conjunction with metronidazole or tinidazole, particularly in cases of intestinal amebiasis, to help eliminate cysts from the intestines[1].

2. Supportive Care

In addition to antimicrobial therapy, supportive care is crucial for managing symptoms and preventing complications:

• Hydration: Maintaining adequate hydration is essential, especially if the patient experiences diarrhea or other gastrointestinal symptoms. Oral rehydration solutions may be recommended to replenish lost fluids and electrolytes[1].

• Pain Management: Analgesics may be prescribed to alleviate pain associated with the infection, particularly pelvic pain or dysuria[1].

Monitoring and Follow-Up

1. Clinical Monitoring

Patients should be monitored for improvement in symptoms and any potential side effects from medications. Follow-up appointments may be necessary to ensure the infection is resolving and to assess for any complications.

2. Laboratory Tests

Follow-up stool examinations or other relevant tests may be conducted to confirm the eradication of the parasite and to monitor for any recurrence of infection[1].

Conclusion

The standard treatment for ICD-10 code A06.82, or other amebic genitourinary infections, primarily involves the use of effective antimicrobial agents such as metronidazole or tinidazole, along with supportive care to manage symptoms. Regular monitoring and follow-up are essential to ensure successful treatment and to prevent complications. If you suspect an amebic infection, it is crucial to consult a healthcare professional for appropriate diagnosis and treatment.

[1] Information derived from standard medical guidelines on the treatment of amebic infections.

ICD-10 code A06.82 refers to "Other amebic genitourinary infections," which encompasses a range of conditions caused by the protozoan parasite Entamoeba histolytica. This code is part of the broader classification of amebic infections, which can affect various systems in the body, particularly the gastrointestinal and genitourinary tracts.

Alternative Names

1. Amebic Cystitis: This term specifically refers to inflammation of the bladder caused by amebic infection, which is classified under the same ICD-10 code.
2. Amebic Urethritis: This term describes an infection of the urethra due to amebic organisms, also falling under the umbrella of genitourinary infections.
3. Amebic Infection of the Genitourinary Tract: A general term that encompasses various infections caused by Entamoeba histolytica in the genitourinary system.

Related Terms

1. Entamoebiasis: This is the general term for infections caused by Entamoeba histolytica, which can manifest in different forms, including intestinal and extraintestinal infections.
2. Amebic Dysentery: While primarily associated with gastrointestinal symptoms, this term is often used in discussions of amebic infections and may relate to genitourinary manifestations in severe cases.
3. Amebic Abscess: Refers to localized collections of pus that can occur in various organs, including the liver and potentially the genitourinary system, although it is not specific to the genitourinary tract.

Clinical Context

Understanding these alternative names and related terms is crucial for healthcare professionals involved in diagnosis, treatment, and coding of amebic infections. Accurate coding ensures proper billing and facilitates research and epidemiological studies related to these infections.

In summary, ICD-10 code A06.82 is associated with various terms that describe infections caused by Entamoeba histolytica in the genitourinary system, highlighting the importance of precise terminology in medical coding and clinical practice.